JAZZ vs META · P/E 1988, rev $2.28B vs P/E 29, rev $60.80B
Jazz Pharmaceuticals PLC (JAZZ) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported META revenue for 2026-06-30 was $60.80B. Net income was $15.85B. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. META currently screens at market cap $1.64T and trailing P/E 28.8.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the JAZZ and META stock pages for the full models.
Not investment advice.